Cambridge Investment Research Advisors, Inc. Zynex Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Oct 24, 2023	SELL	$6.95 - $9.89 $1.82 Million - $2.59 Million	-261,637 Reduced 92.18%	22,188 $178,000
Q2 2023 Jul 13, 2023	BUY	$8.59 - $14.56 $2.44 Million - $4.13 Million	283,825 New	283,825 $2.72 Million

Others Institutions Holding ZYXI

# of Institutions

103

Shares Held

8.4M

Call Options Held

200

Put Options Held

1.5K

Black Rock Inc. New York, NY

1.24M
Shares

$10.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.18M
Shares

$9.9 Million
0.0% of portfolio
Hotchkis & Wiley Capital Management LLC Los Angeles, CA

746K
Shares

$6.27 Million
0.02% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

490K
Shares

$4.12 Million
0.24% of portfolio
Geode Capital Management, LLC Boston, MA

426K
Shares

$3.57 Million
0.0% of portfolio

View Full List

About ZYNEX INC

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $315M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

More about ZYXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account